Detected ·

Kurma Partners

——

Kurma Partners, a member of Eurazeo Group, announces the final closing of its new Biofund IV for €215 million. The fund has already invested in 11 biotech companies and targets around 20 companies, focusing on discovering and developing disruptive therapeutic solutions for serious or incurable diseases.

Amount
—
Stage
—
Event
Funding round
Detected
2026-04-23 16:15:20 UTC
Signal ID
2ed421b6-f091-4568-ab9c-d6a3985d6208

As the API returns it

{
  "id": "2ed421b6-f091-4568-ab9c-d6a3985d6208",
  "created_at": "2026-04-23T16:15:20.896105Z",
  "company_name": "Kurma Partners",
  "company_website_url": "www.kurmapartners.com",
  "company_linkedin_url": "https://www.linkedin.com/company/kurma-life-sciences-partners",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Kurma Partners, a member of Eurazeo Group, announces the final closing of its new Biofund IV for €215 million. The fund has already invested in 11 biotech companies and targets around 20 companies, focusing on discovering and developing disruptive therapeutic solutions for serious or incurable diseases.*"
}

Latest rounds